Literature DB >> 18447253

Serum bFGF concentrations in gastric cancer patients.

I Bilgic1, N Ozalp, M Tez, M Koc.   

Abstract

BACKGROUND: Angiogenetic factors play an important role in the formation of new blood vessels involved in the growth and metastatic spread of solid tumors, but there is limited information regarding the clinical significance of serum bFGF levels in gastric cancer patients. PATIENTS AND METHODS: Serum bFGF concentrations were measured by quantitative sandwich enzyme immunoassay technique in 30 controls and in 30 gastric cancer patients before surgery. The association between preoperative serum bFGF levels and clinical pathological features were evaluated.
RESULTS: Preoperative serum bFGF levels in patients with gastric cancer were significantly higher than those in control patients (p=0.027). On the other hand; there is no relationship between serum bFGF levels and clinical-pathologic parameters in gastric cancer patients.
CONCLUSION: Circulating bFGF might not be a marker suitable for assessing tumor progression (Tab. 1, Ref. 7). Full Text (Free, PDF) www.bmj.sk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18447253

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

1.  MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.

Authors:  J Wang; L Li; M Jiang; Y Li
Journal:  Clin Transl Oncol       Date:  2017-05-12       Impact factor: 3.405

2.  A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.

Authors:  Lei Fan; Wulan Li; Shilong Ying; Lingyi Shi; Zhe Wang; Gaozhi Chen; Hui Ye; Xiaoping Wu; Jianzhang Wu; Guang Liang; Xiaokun Li
Journal:  Tumour Biol       Date:  2015-04-19

3.  Circulating basic fibroblast growth factor in serum of gastric ulcers patient as a biomarker of wound severity.

Authors:  Abdolhossein Shiravi; Fariba Ahmadi; Hadi Parsian; Ziba Shirkhani Kelagari; Durdi Qujeq; Hassan Taheri; Mehrdad Kashifard
Journal:  Caspian J Intern Med       Date:  2011

4.  The -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women.

Authors:  Jan Rykala; Karolina Przybylowska; Ireneusz Majsterek; Grazyna Pasz-Walczak; Andrzej Sygut; Adam Dziki; Piotr Kuna
Journal:  Arch Med Sci       Date:  2014-01-23       Impact factor: 3.318

Review 5.  Collaborating with the enemy: function of macrophages in the development of neoplastic disease.

Authors:  Andrzej Eljaszewicz; Małgorzata Wiese; Anna Helmin-Basa; Michal Jankowski; Lidia Gackowska; Izabela Kubiszewska; Wojciech Kaszewski; Jacek Michalkiewicz; Wojciech Zegarski
Journal:  Mediators Inflamm       Date:  2013-03-17       Impact factor: 4.711

6.  RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?

Authors:  Johann Lechner; Volker von Baehr
Journal:  Int J Gen Med       Date:  2013-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.